SEBI Registration NO.---- INA000001530 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS or messenger.

Top Ten Stocks to be Focused for 22 August 2016

Top Ten Stocks to be Focused for 22 August 2016

Here is a list of top Ten stocks that are likely to be in focus today:

Banking stocks will be in focus after the Appointments Committee of the Cabinet (ACC) on late Saturday announced the appointment of Reserve Bank of India Deputy Governor Urijit Patel as successor to Governor Raghuram Rajan.

United Bank of India: The government will infuse Rs 608 crore in state run United Bank of India soon subscribing to
the bank’s shares at Rs 22.73 including Rs 12.73 premium per share.

Cairn India: Vedanta Ltd’s chief executive said the diversified Indian miner received “constructive feedback” from minority shareholders in Cairn India LtdBSE -1.40 % to a sweetened buyout offer, and was hopeful it can clinch the long-delayed deal.

M&M: Mahindra & Mahindra (M&M) is said to have begun working on what is being pegged as the most affordable electric SUV in the world through its Mahindra Electric unit,  formerly known as Mahindra Reva.

NTPC: The company is expected to report 6 per cent YoY growth in the net profit to Rs 2,270 crore for the quarter endedJune 30, compared with Rs 2,135 crore reported in the year-ago period.

Fortis Healthcare : Fortis Healthcare Limited announced that its board has approved demerger of its diagnostic business into listed subsidiary Fortis Malar HospitalsBSE 19.96 % through a composite scheme of arrangement and amalgamation.

IOCL: A Centre’s green panel has deferred its decision on granting environment clearance to state-run Indian OilBSE 1.08 % Corporation’s Rs 593 crore Styrene and Ethylene project at Panipat in Haryana,

Godrej Group stocks : The Godrej Group is focusing on the inorganic growth route and feels it is a good time to go for more acquisitions, Chairman Adi Godrej said here.

Ranbaxy Laboratories: Sun PharmaBSE -0.84 % seems to have completed the last leg of its massive manpower restructuring post its $3.2-billion acquisition of Ranbaxy Laboratories, with four senior executives exiting the company over the last two months.

Corporation Bank: Corporation Bank seeks members’ nod to issue equity shares on preferential basis to the government of India to the tune of Rs 508 crore.

error: Content is protected !!